EPISODE · Feb 9, 2026 · 16 MIN
Drug Pricing Standoff: Safety Net, Profits, or Both?
from Middle of It · host Middle of It
This episode explores the high-stakes debate over the 340B Drug Pricing Program, analyzing the conflict between safety-net providers and pharmaceutical manufacturers regarding contract pharmacy restrictions, duplicate discounts, and legislative reform. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ilcapitolgroup.substack.com
Embed this episode
NOW PLAYING
Drug Pricing Standoff: Safety Net, Profits, or Both?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.